A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season

Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants

(2012) Naveed Z. Janjua et al.   JOURNAL OF INFECTIOUS DISEASES

A New Sentinel Surveillance System for Severe Influenza in England Shows a Shift in Age Distribution of Hospitalised Cases in the Post-Pandemic Period

(2012) Shelly Bolotin et al.   PLoS One

Effectiveness of an Adjuvanted Monovalent Vaccine Against the 2009 Pandemic Strain of Influenza A(H1N1)v in Stockholm County, Sweden

(2011) A. Ortqvist et al.   CLINICAL INFECTIOUS DISEASES

Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain

(2011) D. M. Skowronski et al.   CLINICAL INFECTIOUS DISEASES

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

(2011) Jacqueline M Katz et al.   Expert Review of Anti-Infective Therapy

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

(2011) M. L. B. Hillaire et al.   JOURNAL OF GENERAL VIROLOGY

Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection

(2011) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/Yamagata

(2011) Danuta M. Skowronski et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: Population-based case–control study

(2011) Salaheddin Mahmud et al.   VACCINE

Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children

(2011) Vladimir Gilca et al.   VACCINE

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

(2010) Lisa A Jackson et al.   BMC INFECTIOUS DISEASES

Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic

(2010) D. M. Skowronski et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong

(2010) Benjamin J. Cowling et al.   CLINICAL INFECTIOUS DISEASES

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

(2010) Sharon Frey et al.   CLINICAL INFECTIOUS DISEASES

The Shifting Demographic Landscape of Pandemic Influenza

(2010) Shweta Bansal et al.   PLoS One

Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada

(2010) Danuta M. Skowronski et al.   PLOS MEDICINE

Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines

(2009) Arnold S. Monto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort

(2009) Stephanie A. Irving et al.   VACCINE

Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007

(2008) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Using Surveillance to Evaluate Influenza Vaccine Effectiveness

(2008) Lisa A. Jackson   JOURNAL OF INFECTIOUS DISEASES